Abstract
The I1307K APC germline mutation is associated with an increased risk to colorectal cancer (CRC). Whether and to what extent the somatic features and the molecular pathways of cancer development in mutation carriers differ from colorectal cancer in noncarriers remains unknown. To gain insight into this issue, 52 Israeli patients with CRC, 24 of whom were I1307K APC mutation carriers, were analyzed. The expression pattern of genes known to be involved in the pathogenesis of sporadic CRC was assessed immunohistochemically: E-cadherin, ß-catenin, deleted in colon cancer (DCC), and p53. In addition, tumors were genotyped for somatic activating mutations in Ki-rasoncogene. Mutation carriers and noncarriers were comparable in age at diagnosis (64.3 ± 10.1 years for carriers and 60.8 ± 14.1 years for noncarriers), tumor location in the colon, and disease stages. Tumors of I1307K mutation carriers displayed positive p53 immunostaining and loss of ß-catenin, E-cadherin, and DCC expression more often compared with noncarriers, although none of these differences reached statistical significance. Mutation frequencies in the Ki-ras gene were similar in both groups. In conclusion, the molecular pathways in CRC in I1307K APC mutation carriers are seemingly similar to those of sporadic cases, but a larger study is clearly needed.
Similar content being viewed by others
References
Laken SJ, Petersen GM, Gruber SB Oddoux C, Ostrer H, Giardiello FM, Hamilton SR, Hampel H, Markowitz A, Klimstra D, Jhanwar S, Winawer S, Offit K, Luce MC, Kinzler KW, Vogelstein B: Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet 17:79-83, 1997
Woodage T, King SM, Wacholder S, Hartge P, Struewing JP, McAdams M, Laken SJ, Tucker MA, Brody LC: The APC I1307K allele and cancer risk in a community-based study of Ashkenazi Jews. Nat Genet 20:62-65, 1998
Rozen P, Shomrat R, Strul H, Naiman T, Karminsky N, Legum C, Orr-Urtreger A: Prevalence of the I1307K APC gene variant in Israeli Jews of differing ethnic origin and risk for colorectal cancer. Gastroenterology 116: 54-57, 1999
Gryfe R, Di Nicola N, Lal G, Gallinger S, Redston M: Inherited colorectal polyposis and cancer risk of the APC I1307K polymorphism. Am J Hum Genet 64:378-384, 1999
Figer A, Shtoyerman-Chen R, Tamir A, Geva R, Irmin L, Flex D, Theodor L, Sulkes A, Sadetzki S, Bar-Meir S, Friedman E: Phenotypic characteristics of colo-rectal cancer in I1307K APC germline mutation carriers compared with sporadic cases. Br J Cancer 85:1368-1371, 2001
Takayama T, Ohi M, Hayashi T, Miyanishi K, Nobuoka A, Nakajima T, Satoh T, Takimoto R, Kato J, Sakamaki S, Niitsu Y: Analysis of K-ras, APC, and beta-catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposis: Gastroenterology 121:599-611, 2001
Vasen HF, Watson P, Mecklin JP, Lynch HT: New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 16:1453-1456, 1999
Shtoyerman-Chen R, Friedman E, Figer A, Carmel M, Patael Y, Rath P, Fidder HH, Bar-Meir S, Theodor L: The I1307K APC polymorphism: prevalence in non-Ashkenazi Jews and evidence for a founder effect. Genet Test 5:141-146, 2001
Theodor L, Melzer E, Sologov M, Idelman G, Friedman E, Bar-Meir S: Detection of pancreatic carcinoma: diagnostic value of K-ras mutations in circulating DNA from serum. Dig Dis Sci 44:2014-2019, 1999
Gumbiner BM: Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 84:345-357, 1996
Guesdon JL, Ternynck T, Avrameas S: The use of avidin—biotin interaction in immunoenzymatic techniques. J Histochem Cytochem 27:1131-1139, 1979
Drucker L, Shpilberg O, Neumann A, Shapira J, Stackievicz R, Beyth Y, Yarkoni S: Adenomatous polyposis coli I1307K mutation in Jewish patients with different ethnicity: prevalence and phenotype. Cancer 88:755-760, 2000
Syngal S, Schrag D, Falchuk M, Tung N, Farraye FA, Chung D, Wright M, Whetsell A, Miller G, Garber JE: Phenotypic characteristics associated with the APC gene I1307K mutation in Ashkenazi Jewish patients with colorectal polyps. JAMA 284:857-860, 2000
Polakis P: The adenomatous polyposis coli (APC) tumor suppressor. Biochim Biophys Acta 1332:F127-F147, 1997
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fidder, H.H., Chen-Shtoyerman, R., Barshack, I. et al. Immunohistochemical Analyses of Colon Cancer in I1307K APC Mutation Carriers Compared with Noncarriers. Dig Dis Sci 48, 1102–1105 (2003). https://doi.org/10.1023/A:1023764728863
Issue Date:
DOI: https://doi.org/10.1023/A:1023764728863